Mononucleosis primary prevention: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{Mononucleosis}} {{CMG}} ==Overview== Maj...")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
{{Mononucleosis}}
{{Mononucleosis}}
{{CMG}}
{{CMG}}

Revision as of 16:28, 20 December 2012

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Mononucleosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Epidemiology and Demographics

Risk Factors

Causes

Differentiating Mononucleosis from other Diseases

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mononucleosis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mononucleosis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mononucleosis primary prevention

CDC on Mononucleosis primary prevention

Mononucleosis primary prevention in the news

Blogs on Mononucleosis primary prevention

Directions to Hospitals Treating Mononucleosis

Risk calculators and risk factors for Mononucleosis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Majority of mononucleosis syndromes are caused by Epstein-Barr virus, and most people become infected with EBV sometime during their lives with an estimated 90-95% population aged more than 21 years demonstrate antibody to EBV.[1][2] The transmission of the virus requires intimate contact with the saliva of an infected person and rarely occurs via air or blood. Therefore, the most reasonable way to prevent mono is to avoid close contact with infected saliva.

References

  1. Henle G, Henle W, Clifford P, Diehl V, Kafuko GW, Kirya BG, Klein G, Morrow RH, Munube GM, Pike P, Tukei PM, Ziegler JL (1969). "Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups". Journal of the National Cancer Institute. 43 (5): 1147–57. PMID 5353242. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  2. Pereira MS, Blake JM, Macrae AD (1969). "EB virus antibody at different ages". British Medical Journal. 4 (5682): 526–7. PMC 1630375. PMID 4902364. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)


Template:WikiDoc Sources